FORM 6-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 July 16, 2007 Commission File Number 001-14978 SMITH & NEPHEW plc (Registrant's name) 15 Adam Street London, England WC2N 6LA (Address of registrant's principal executive offices) [Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.] Form 20-F X Form 40-F --- --- [Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1).] Yes No X --- --- [Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7).] Yes No X --- --- [Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing information to the Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of 1934.] Yes No X --- --- If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2 (b) : 82- n/a. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Smith & Nephew plc (Registrant) Date: July 16, 2007 By: /s/ Paul Chambers ----------------- Paul Chambers Company Secretary Timing of Smith & Nephew Second Quarter and Interim Results 16 July 2007 Smith & Nephew plc will be announcing its second quarter and Interim results ending 1 July 2007 on Thursday 2 August 2007 at 11am BST/6am Eastern. This will be followed by a presentation for financial analysts at 1pm BST/8am Eastern, which can be seen live via webcast on the Smith & Nephew website at www.smith-nephew.com and available on the site archive shortly afterwards. About Us Smith & Nephew (LSE: SN.L; NYSE: SNN) is one of the world's leading medical device companies, specialising in Orthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies. Smith & Nephew is dedicated to helping improve people's lives. The company prides itself on the strength of its relationships with its surgeon and healthcare professional customers, with whom its name is synonymous with the highest standards of performance, innovation and trust. The company has over 8,800 employees and operates in 31 countries around the world, generating sales of $2.8 billion. Enquiries: Smith & Nephew UK Julie Allen Tel: +44 (0)20 7401 7646 Corporate Affairs co-ordinator Media Jon Coles +44 (0) 20 7404 5959 Brunswick - London Cindy Leggett-Flynn +1 (212) 807 8319 Brunswick - New York